Applications of Accelerators and Detectors to Cancer Treatment

Abstract:

A key challenge in particle therapy today is quality assurance during treatment, which needs advanced medical imaging techniques. This issue is tackled by the EC funded project ENVISION, an R&D consortium of sixteen leading European research centres and one industrial partner, co-ordinated by CERN. ENVISION covers developments in Time Of Flight in-beam PET, in-beam single particle tomography, organ motion monitoring techniques, simulation, and treatment planning. Additionally, ENVISION serves as a training platform for the ENTERVISION project, a Marie-Curie Initial Training Network aimed at educating young researchers in online 3D digital imaging for hadron therapy. ENTERVISION brings together ten academic institutes and research centres of excellence and a leading European company in particle therapy, and is coordinated by CERN. Its multi-disciplinary training programme of ENTERVISION includes a diversified portfolio of scientific courses, complemented by specific courses aimed at developing soft skills. The ENTERVISION researchers will also benefit from the involvement in the research activity of ENVISION, and in the European Network for Light Ion Hadron Therapy (ENLIGHT). The trainees are encouraged to build a multidisciplinary network which will not only help them with their future careers but ultimately improve the transfer of knowledge and collaboration between the various disciplines of cancer treatment.